DFX Intelligence
Private Equity Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Firms / G••••• P•••• C••••••• L••
G••••• P•••• C••••••• L••
Classification
- Class
- Buyout firmconfirmed, confidence 85%
- Basis
- R6: 6 of 6 distinct vehicles are sworn Private Equity Funds; 5 reported gross assets on a filing in 2022 or later
- Size band
- Middle marketdefined by: proxy: $3.57bn Private Equity Fund GAV on the Form ADV filed 2023-09-29
Classification history (1)
- Sep 13, 2026Buyout firm (confirmed, 85%, cls-pe-1)R6: 6 of 6 distinct vehicles are sworn Private Equity Funds; 5 reported gross assets on a filing in 2022 or later
Regulatory footprint (Form ADV)
- Adviser type
- registered investment adviser
- Form ADV filings
- Sep 29, 2023 to Sep 29, 2023
- RAUM
- $3.2Bregulatory assets under management of the adviser; not dry powder, not a fund size
- PE funds, latest filing
- 6
- PE fund GAV, latest filing
- $3.6Breported gross assets (Form ADV), not fund size
- All private fund GAV
- $3.6Bevery private fund type, latest filing
- 2024 PE fund GAV
- unknownsum over funds typed Private Equity Fund with a 2024 or later as-of date
- PE share of funds, lifetime
- 100%
- Fund type mix
- filed 2023-09-29, latest gav Private Equity Fund $3.6B, latest counts Private Equity Fund 6, lifetime distinct Private Equity Fund 6
- Employees
- 17
- Headquarters
- Cambridge, MA
- Office address
- 55 CAMBRIDGE PARKWAY, Cambridge, MA, 02142
- Business phone
- 6175884900
Stated criteria beside observed behaviour
4 observed deals
Stated by the firm
- Sectors
- not stated or not yet read
- Geography
- not stated or not yet read
- Revenue
- not stated or not yet read
- EBITDA
- not stated or not yet read
- Enterprise value
- not stated or not yet read
- Equity check
- not stated or not yet read
- Control
- not stated or not yet read
- Thesis
- B-FLEXION seeds, acquires and builds investment partnerships, and also makes principal investments in operating businesses in transformative industries.
Observed from deals on record
- roles
- unknown 1, platform 4
- period
- to 2026-01-12, from 2018-11-27, undated holdings 1, dated observations 8
- window
- last 2026-01-12, first 2018-11-27
- control
- control 4, unknown 1
- companies
- 4
- geography
- investments
- 5
- seller kinds
- transactions
- 4
- cadence by year
- 2018 platforms 1, 2023 platforms 1, 2026 platforms 2
- platform add on
- add ons 0, platforms 4, add ons per platform 0
- sector known for
- 1
- disclosed value usd
- n 0
- sector distribution
- count 1, share 0.25, value industrial manufacturing, examples Corium International
- holding period years
- n 0
- repeat counterparties
- role financial adviser, shared 2, entity id de9947a4-c3d2-494d-8dc1-369b4cc8d65a
- subsector distribution
- count 1, share 0.25, value miscellaneous manufacturing, examples Corium International
4 companies on the graph (4 transactions); most in industrial manufacturing (1); 4 platforms and 0 add-ons; observed 2018 to 2026
Funds
6 on record
| Fund | Vehicle | Vintage | Reported gross assets (Form ADV), not fund size | GAV by year | Form D sold | Lifecycle |
|---|---|---|---|---|---|---|
| G••••• P•••• L• ADV: Private Equity Fund | buyout or unlabelled | unknown | $2.4B as of Sep 29, 2023 | no Form D | Unknown | |
| G•• W• F••• L• ADV: Private Equity Fund | buyout or unlabelled | unknown | $516M as of Sep 29, 2023 | no Form D | Unknown | |
| G•• R••••••••• A••••••••• G• L•• ADV: Private Equity Fund | buyout or unlabelled | unknown | $257M as of Sep 29, 2023 | no Form D | Unknown | |
| G•• G••••• A••••••••• L• ADV: Private Equity Fund | buyout or unlabelled | unknown | $235M as of Sep 29, 2023 | no Form D | Unknown | |
| G••••• P•••• N••• L• ADV: Private Equity Fund | buyout or unlabelled | unknown | $157M as of Sep 29, 2023 | no Form D | Unknown | |
| G••••• P•••• I• L••• ADV: Private Equity Fund | buyout or unlabelled | unknown | $0 as of Sep 29, 2023 | no Form D | Unknown |
Team
15 current, 0 former
Managing partner (3)
- C••••••••• V••••••••• · Managing Partner · start date unknown Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
- E•••••• S••••• M••••••• B••••••••• · Chairman · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- S••••• M•••••• · Vice-Chairman · start date unknown Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
Partner (5)
- E•••••• S••••• M••••••• B••••••••• · Owner · since Aug 1, 2023 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- O••••• H••••• · Managing Director, Group Investments · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- S••••• S•••••• · Partner · start date unknown Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
- S••••• S•••••• · Partner · since Oct 1, 2022 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- T••••• W••••• · Partner · since Nov 1, 2015 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
Operating partner (4)
- N••••• D•••••• · Operating Partner · start date unknown Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
- N••••• D•••••• · Operating Partner · start date unknown Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
- P•••• A•••• · Operating Partner, B•••••••• Life Sciences · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- S••••• R••••• · Operating Partner, B•••••••• Life Sciences · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
Platform (2)
- A••• D••••••• · Chief Compliance Officer, General Counsel · since May 1, 2019 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- S•••• C••••••• · Group CFO, Partner and Member of the Board · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
Other (1)
- R•••••• K••••••• · Head of Asset Management Investments · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
Portfolio
5 relationships, 4 platforms, 0 add-ons
| Company | Role | Status | Invested | Held | Partner | Source |
|---|---|---|---|---|---|---|
| R•••••••• 5•• I••••••• | Platform | active | Jan 12, 2026 transaction announcement | 8 months | N••••• D•••••• (confirmed) | Fact Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS) |
| R•••••••• 5•• I••••••• | Platform | active | Jan 12, 2026 transaction announcement | 8 months | N••••• D•••••• (confirmed) | Fact Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS) |
| P•••••• P••••••••• | Platform | active | Jun 6, 2023 transaction announcement | 3.3 years | S••••• S•••••• (confirmed) | Fact Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS) |
| C••••• I••••••••• | Platform | active | Nov 27, 2018 transaction announcement | 7.8 years | C••••••••• V••••••••• (confirmed) | Fact Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS) |
| A•••••• G•••• | Role unknown | exited exited Apr 19, 2022 | unknown | unknown | unknown | Fact Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS) |
Transactions
4 on record
| Date | Type | Target | This firm’s role | Source |
|---|---|---|---|---|
| Jan 12, 2026 | Platform acquisition | R•••••••• 5•• I••••••• | Sponsor (confirmed), Sponsor (confirmed) | bflexion.com |
| Jun 6, 2023 | Platform acquisition | P•••••• P••••••••• | Sponsor (confirmed) | bflexion.com |
| Apr 19, 2022 | Exit to a strategic buyer | A•••••• G•••• | Seller (confirmed) | bflexion.com |
| Nov 27, 2018 | Platform acquisition | C••••• I••••••••• | Sponsor (confirmed) | bflexion.com |
Placement agents, lenders, advisers and co-investors
6 relationships
Financial advisers (3)
- L••••• 1 shared · one time · last Jun 6, 2023
- M••••• • C•••••• L•• 1 shared · one time · last Jun 6, 2023
- C••••••••• P••••••• L•• 1 shared · one time · last Jan 12, 2026
Legal advisers (3)
- L••••• • W•••••• L•• 1 shared · one time · last Jun 6, 2023
- R•••• • G••• L•• 1 shared · one time · last Jun 6, 2023
- G•••••• P•••••• 1 shared · one time · last Jun 6, 2023
LP commitments
0 disclosed
No LP commitment collected yet. An LP edge needs a public disclosure with a quote, such as a pension plan’s report or an announcement naming the LP.
Events
42 most recent
- Sep 1, 2026Adviser CRD 320759 is not on the SEC registered or exempt adviser roster of 2026-09-01
- Apr 29, 2026CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing Wed, 04/29/2026 - 16:47
- Mar 18, 2026P•••••• P••••••••• Completes Combination with Radius Health, Expanding Its Multi-Product Specialty Commercial Platform Wed, 03/18/2026 - 15:28
- Jan 12, 2026B-FLEXION Life Sciences to Acquire R•••••••• 5•• I••••••• in Radius Health Mon, 01/12/2026 - 16:55
- Jan 12, 2026B-FLEXION Life Sciences to Acquire R•••••••• 5•• I••••••• in Radius Health Mon, 01/12/2026 - 16:55
- May 23, 2025Crosstree Real Estate Partners Acquires Argyll, London's Premier Serviced Office Provider Fri, 05/23/2025 - 12:57
- May 21, 2025P•••••• P••••••••• Completes Acquisition of Optinose, Creating an Expanded Portfolio of Specialty Therapies Wed, 05/21/2025 - 13:48
- May 14, 2025GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD) Wed, 05/14/2025 - 10:58
- Mar 20, 2025P•••••• P••••••••• to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS) Thu, 03/20/2025 - 09:34
- Jul 25, 2024Twelve Capital and Securis announce merger to create a leader in Insurance-Linked Securities (ILS) Thu, 07/25/2024 - 11:21
- Oct 3, 2023Allergy Partners Announces Acquisition of Charleston Allergy and Asthma Tue, 10/03/2023 - 14:50
- Sep 29, 2023G••••• P•••• C••••••• L•• first filed Form ADV in the extract (IA)
- Sep 18, 2023Allergy Partners Appoints Chris Kane as Chief Executive Officer Mon, 09/18/2023 - 15:55
- Jun 7, 2023P•••••• P••••••••• to be Acquired by G••••• P•••• C•••••• and Novo Holdings Wed, 06/07/2023 - 08:10
- Jun 6, 2023P•••••• P••••••••• to be Acquired by G••••• P•••• C•••••• and Novo Holdings Wed, 06/07/2023 - 08:10
- Jan 26, 2023GPC's Innocoll Holdings Ltd. Appoints Kimball Hall as Chief Executive Officer Thu, 01/26/2023 - 16:20
- Oct 21, 2022C••••• and G••••• P•••• C•••••• Announce Manufacturing Business Acquisition and a $100 Million Neuroscience Therapeutics Investment by Webster Equity Partners Fri, 10/21/2022 - 12:17
- Sep 28, 2022Capital Four's Private Debt III Fund closes above target and at hard cap of €1.5 billion Wed, 09/28/2022 - 16:28
- Sep 13, 2022Allergy Partners joins Consortium of Independent Immunology Clinics (CIIC) Tue, 09/13/2022 - 15:23
- Jun 23, 2022Radius Health Announces Agreement to be Acquired by G••••• P•••• C•••••• and Patient Square Capital Thu, 06/23/2022 - 15:37
- May 24, 2022P•••• Sanborn Joins Arbor Ventures as General Partner; will lead Arbor B-FLEXION Growth Fund Tue, 05/24/2022 - 14:37
- May 10, 2022Boston P••••••••• Appoints Dr. Sophie Kornowski as Chair of its Board of Directors and Acting Chief Executive Tue, 05/10/2022 - 15:59
- Apr 19, 2022B-FLEXION Sells A•••••• G•••• to GBL Tue, 04/19/2022 - 08:00
- Apr 19, 2022B-FLEXION Sells A•••••• G•••• to GBL Tue, 04/19/2022 - 08:00
- Feb 22, 2022Forestay Invests Again in Zenjob Tue, 02/22/2022 - 09:53
- Feb 9, 2022Forestay investment, Scandit, goes Unicorn with Series D Wed, 02/09/2022 - 15:43
- Feb 3, 2022Forestay portfolio investment, BlueBotics, acquired by ZAPI Thu, 02/03/2022 - 10:54
- Dec 23, 2021Waypoint Capital Acquires Majority Stake in Allergy Partners Thu, 12/23/2021 - 14:56
- Jan 8, 2020Waypoint Capital Appoints Elias Zerhouni to Board of Directors Wed, 01/08/2020 - 13:19
- Sep 26, 2019GPC's Portfolio Investment, Before Brands, Secures Backing from Nestle Health Science Thu, 09/26/2019 - 12:57
- Sep 23, 2019Forestay Capital Invests in Kandou, a global leader in connectivity IP and chip solutions Mon, 09/23/2019 - 11:20
- May 14, 2019Forestay Capital invests in icometrix, the brain imaging AI leader Tue, 05/14/2019 - 15:40
- Nov 27, 2018G••••• P•••• C•••••• Completes Acquisition of C••••• I•••••••••, Inc. Tue, 11/27/2018 - 18:05
- Nov 27, 2018G••••• P•••• C•••••• Completes Acquisition of C••••• I•••••••••, Inc. Tue, 11/27/2018 - 18:05
- Sep 26, 2018Forestay Capital Invests in Swiss Navigation Company, BlueBotics Wed, 09/26/2018 - 14:36
- Sep 17, 2018Forestay Capital Invests in Cloud Storage Company, Wasabi Mon, 09/17/2018 - 15:14
- May 22, 2018Waypoint Appoints New Group General Counsel Tue, 05/22/2018 - 12:15
- Jan 26, 2018A•••••• G•••• Appoints New Chief Executive Officer Fri, 01/26/2018 - 11:02
- Apr 5, 2017G••••• P•••• L.P. enters into agreement to acquire Innocoll Holdings plc Wed, 04/05/2017 - 07:58
- Dec 7, 2016G••••• P•••• Invests $92M in Primary Care Innovator Crossover Health Wed, 12/07/2016 - 13:36
- Oct 6, 2016G••••• P•••• C•••••• Invests in BEFORE Brands, a science-based consumer products company dedicated to bringing innovative, proprietary nutritional products directly to families Thu, 10/06/2016 - 12:09
- Jun 23, 2015Waypoint appoints Chris V••••••••• to lead healthcare investment strategy Tue, 06/23/2015 - 15:45
Across the graphs
G••••• P•••• C••••••• L•• is the same institution as 1 record in RIA and Wealth.
RIA and Wealth1
Which record it is in each graph, what it is called there, and what the two were joined on. The Data Factory holds all nine graphs and the identity layer between them.
Checking your plan…